Arrowstreet Capital
UTMD icon

Arrowstreet Capital’s Utah Medical Products UTMD Stock Holding History

Arrowstreet Capital’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Hold
5,328
– – ﹤0.01% 1722
2025
Q4 		$298K Hold
5,328
– – ﹤0.01% 1735
2025
Q3 		$336K Hold
5,328
– – ﹤0.01% 1749
2025
Q2 		$303K Hold
5,328
– – ﹤0.01% 1834
2025
Q1 		$299K Hold
5,328
– – ﹤0.01% 1686
2024
Q4 		$328K Sell
5,328
-596
-10% -$38.5K ﹤0.01% 1609
2024
Q3 		$396K Buy
+5,924
New +$402K ﹤0.01% 1552
2021
Q1 		– Sell
-5,100
Closed -$430K – 2550
2020
Q4 		$430K Buy
5,100
+1,500
+42% +$128K ﹤0.01% 2045
2020
Q3 		$288K Buy
+3,600
New +$299K ﹤0.01% 2147

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital's UTMD Position: Q1 2026 in Review

Arrowstreet Capital held its Utah Medical Products (UTMD) position steady in Q1 2026 at 5,328 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #1722.

Arrowstreet Capital first reported a position in UTMD in Q3 2020 and has held it in 9 quarters since. The position peaked at $430K in Q4 2020. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Arrowstreet Capital held 5,328 shares of Utah Medical Products worth $330K as of Q1 2026.
  • Arrowstreet Capital left its Utah Medical Products share count unchanged in Q1 2026.
  • Utah Medical Products made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1722 holding.
  • Arrowstreet Capital first reported a position in Utah Medical Products in Q3 2020 and has held it in 9 quarters since.
  • Arrowstreet Capital's Utah Medical Products position peaked at $430K in Q4 2020.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.